Emory, Georgia Tech, and GCMI collaborate to Combat Influenza
Announced recently via the Georgia Tech News Center, Microneedle Patches for flu vaccination were found safe to use following a successful human clinical trial. “Despite the potentially severe consequences of illness and even death, only about 40 percent of adults in the United States receive flu shots each year,” writes Holly Korschun, Director, Research Communications…